Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanochirality-programmed type-I photosensitizer enables deep-tumor photodynamic therapy by reducing extracellular-matrix adhesion

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114572Source: DataRank Database

Nanochirality-programmed type-I photosensitizer enables deep-tumor photodynamic therapy by reducing extracellular-matrix adhesion is a research paper published in Journal of Controlled Release (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: hybridTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Gaeun Kim ORCID,Runyao Zhu ORCID,Hyunsu Jeon ORCID,Yichun Wang ORCID,Yichen Liu ORCID

Live enrichment

PubMed:41443348 PMC:PMC12989812 OpenAlex:https://openalex.org/W7116709205

National Institute of General Medical Sciences

Grant: 1R35GM15608-01

National Science Foundation

Grant: CBET-2337387

University of Notre Dame

Grant: 374553 28016

NIGMS NIH HHS

Grant: R35 GM150608

NCI NIH HHS

Grant: R21 CA277663

National Institutes of Health

FWCI

0.00

Citation Percentile

0.4%

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jconrel.2025.114572

publisherhttps://doi.org/10.1016/j.jconrel.2025.114572

publisherhttps://api.elsevier.com/content/article/PII:S0168365925011861?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365925011861?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41443348

Fields of Study

Nanoplatforms for cancer theranosticsCarbon and Quantum Dots ApplicationsGraphene and Nanomaterials ApplicationsPhotochemotherapyPhotosensitizing AgentsExtracellular MatrixAnimalsHumansReactive Oxygen SpeciesIndocyanine GreenNeoplasmsQuantum DotsCell Line, TumorGraphiteHyaluronic AcidMiceTumor MicroenvironmentFemale

MeSH Terms

AnimalsExtracellular MatrixFemaleGraphiteHumansHyaluronic AcidIndocyanine GreenNeoplasmsPhotochemotherapyPhotosensitizing AgentsReactive Oxygen SpeciesQuantum DotsCell Line, TumorMiceTumor Microenvironment

Keywords

Photodynamic therapyPhotosensitizerReactive oxygen speciesTumor hypoxiaTumor microenvironmentOxidative stressPenetration (warfare)Extracellular matrixChiralitySolid tumorGraphene Quantum DotType-i Reactive Oxygen Species

Nanochirality-programmed type-I photosensitizer enables deep-tumor photodynamic therapy by reducing extracellular-matrix adhesion

FAIR Checklist

Authors (5)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)